The record, in one place.
Who funds the research, who validates the methods, what is protected, and where the instruments actually run. No competitor can copy a regulatory position; this page is ours, with the references to check it.
Grants & public funding
Grants & public funding
Roughly 70% of AWLabs R&D is covered by competitive public funding: €1.9M+ in active grants and pipeline.
| Program | Role | Amount | Status |
|---|---|---|---|
| PANDA (EU Horizon) | Consortium coordinator | €700K | Active |
| MEDIC | Hospital use-case lead | — | Active |
| Groove | Project partner | — | Active |
| DETECT-WHO | Detection research partner | — | In progress |
| DEFRA | Research partner | — | In progress |
Final per-program figures are being consolidated for publication; the €1.9M+ total is current.
Patents
Patents
AirShield
Governance and analytics system. Filed Q1 2026 via Calysta.
Sentinel
Real-time airborne pathogen detection platform. Filed Q1 2026 via Calysta.
Publications
Publications
AWLabs publishes with its clinical and academic partners rather than about itself. The joint publications with UZ Brussel (Johan Guns) opened the European regulatory debate on biological IAQ standards; the validation work with ULB CREST (Carlo Iorio) underwrites the analytical methods. The complete list, with authors, journals, years, and DOIs, is being compiled for this page and will carry links to every public record.
Institutional partners
Institutional partners
VITO
Flemish institute for technological research: environmental measurement science
IssEP
Walloon public institute: reference analyses and environmental monitoring
Sciensano
Belgian institute for public health: biological risk expertise
ULB / CREST
Reference laboratory for indoor air quality: method validation and accreditation
The field record
Where the instruments run.
Deployments are how the laboratory gets its data, and they are also the clearest answer to whether anyone wants this. Both readings are below.
| Institution | Location | Relationship |
|---|---|---|
| UZ Brussel | Brussels, Belgium | Clinical deployment partner · first case study in progress |
| St. Luke's International Hospital | Tokyo, Japan | Clinical partner |
| ERETZ.bio / Hospital Albert Einstein | São Paulo, Brazil | Clinical partner |
| Swansea University | Swansea, United Kingdom | Research partner |
| Bispebjerg Hospital | Copenhagen, Denmark | Clinical partner |
Named with each institution’s agreement. The site-by-site split between proof of concept, research deployment, and clinical pilot is being confirmed with each partner before it is published here.
10 hospital letters of intent. In conversion across Europe and beyond through 2026. The institutions are not named: an LOI is not a signed contract, and publishing a logo before there is one is the practice this site refuses.
Commercial and infrastructure partners
Proximus NXT
Connectivity and data infrastructure
Daikin
HVAC integration
Equans
Building services deployment
Lyreco
Workplace environment
Where the risk concentrates
Three environments, one failure mode.
The instruments are built for the places where an undetected airborne hour is most expensive. Not three markets: three versions of the same unmeasured variable.
Hospitals & care
Healthcare-associated infections, EN ISO 14644 classification, JCI and HAS accreditation cycles. When an outbreak is investigated, the question is what the institution measured — and air is the one vector with no answer.
Pharma & laboratories
GMP clean rooms under FDA and EMA expectations that keep moving from periodic sampling toward continuous, documented environmental control. A biological excursion caught late is a lost batch.
Critical buildings
WELL certification and ESG disclosure are pulling indoor environmental quality onto the balance sheet. Biology is the part of it nobody can currently report.
Regulatory trajectory
Where European IAQ regulation is going, and where we stand in it
European IAQ rules address comfort and chemistry: CO₂, particulates, ventilation rates. Airborne biology is unregulated.
Joint publications with UZ Brussel put biological IAQ standards on the European regulatory agenda.
Working groups move toward measurable biological criteria for critical environments. Reference methods are being selected now.
Patented detection, accredited validation partners, and an EU consortium coordination role: the method regulators can point to.
Want the underlying documents?
Grant references, patent filings, publication records, and the deployment detail behind this page are available to qualified partners, research institutions, and investors on request.